A large observational study using US healthcare claims and electronic health record data suggests that Moderna’s updated 2024 ...
6don MSNOpinion
Moderna chair says US assault on science is just beginning
Moderna Inc.’s chairman says the Trump administration’s vaccine policy changes are part of a broader attack on science that ...
Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual ...
The complaint alleges that Moderna used the patented fluorescent protein technology without permission during preclinical ...
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data ...
Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...
In early January 2026, Moderna filed for marketing authorization of its investigational seasonal influenza vaccine mRNA-1010 ...
Moderna CEO Stéphane Bancel positions 2026 as a catalyst-rich year driven by new vaccine launches, late-stage oncology data, ...
CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback